Have-no-idea-if-last-names-are-related-or-not only read from the public information that there is a common last name.

No-humor-implied-no-libel-inferred-intent-was-to-share-public-information and let others determine for themselves if information is pertinent.
As a long investor this is some of the information evaluated when determining to hold a position.

Many investors feel stock market is rigged, but that does not suggest they stop investing or investigating related information.

The information referenced is publicly accessible and if there is any liability would seem related to source of that publicly available information, not with the information being referenced on a forum.

You-need-to-look-closer-;)

Just-facts-that-help-facilitate-due-diligence
There are risks in all facets of investing, being informed is good characteristic to emulate.

Being aware that the SEC has filed against close members is good insight. No guilt by association inferred.

See-if-this-helps-to-provide-insights
www.theoaklandpress.com/article/OP/20110116/NEWS/301169956
Pay close attention to the names involved.

www.sec.gov/litigation/complaints/2011/comp21813.pdf

Not-all-companies-operate-with-your-level-of-integrity
Encourage googling "Grace-Holdings" and make note of the names associated to the filings and what the filings pertain to.

Were-you-selling-shares-to-the-public-to-repay-the-loans
Family loans knowing you have a business model to repay is slightly different then repaying based on diluting investors valuation.

Look-into-concepts-behind-family-loans-as-well-Grace-Holdings-associated-names

OS-Likely-above-11B-when-reported-in-March-or-April-2016
Expecting OS to be well above 11B by the time un-audited financials reported in March/April time-frame.

If OS increasing, then Losses increasing, any speculation about profitable in Q1 or Q2 are likely fabricated on being paid to disseminate such disinformation.

Just-for-a-moment-speculate-if-company-reports-similar-loss-in-March
Since willing to speculate on Profits, what will be your stance if the company reports losses and profits do not materialize as you have speculated in what is probably approaching over 100 different posts?

Just for 1 minute what if company continues to report losses, then what?

What would be the rationalization then?

You must have given this "Continued Losses" potential some consideration?

Similar-transparency-from-company-would-bolster-investors
Your transparency is similar to what the company should adopt.
Kinda the little guy against Goliath or the Machine.....
The lack of transparency is actually reducing companies potential on all facets. Honest rational from company in my opinion would only help solidify the companies base and potentially bring interest from those willing to help with FDA logistics for the sake of helping the little guy and those being hurt by the machine with prescription drugs.
Again, assuming no Tom Foolery exists

Something-is-rotten-in-the-state-of-Denmark
A line from the play Hamlet, by William Shakespeare. An officer of the palace guard says this after the ghost of the dead king appears, walking over the palace walls. Note : “Something is rotten in the state of Denmark” is used to describe corruption or a situation in which something is wrong.

Struggle-to-rationalize-why-family-loans-if-viable-product
If J&J were interested in any facet they would have made the family "An offer they could not refuse."

Likewise Chattem "Icy-Hot" would not have brought Smart-Relief to market and instead would have acquired rights to this product.

"Something is rotten in the state of Denmark"

Opinion-is-70%-Share-Selling-Strategy-30%-Product-Selling-Strategies
If the company provided greater transparency then both strategies "Share Selling" & "Product Adoption" could be accelerated.
Assuming there is viable/legitimate transparency.

Reiterate-opinion-to-only-accumulate-shares-near-5-year-lows
Only invest what willing to loose
Probability higher that PPS will approach zero before FDA Clearance
If company does not have pool of uninformed investors to sell shares to, then will be motivated to allocate funding to ensuring FDA Clearance
Currently its possible family and friends taking free ride on backs on unsuspecting investors

Long-every-0.0001-PPS-results-in-$10k-loss-or-gain

sh#t-loads-would-allow-you-to-buy-all-outstanding-shares
By definition ;)
Its all relative, would only cost you 10M to buy all Outstanding shares;)
Realistically though, none of us would be on this forum if we owned sh#t loads of this stock.

Suggest-targeting-50%-losses-before-accumulating-more
Personally would not accumulate above 5 year low.
IE: In same range where PPS reached Feb-10-2014

Pot-calling-kettle-black-currency-rates-is-weighted-relevancy
If J&J were interested in any facet they would have made the family "An offer they could not refuse."

Likewise Chattem "Icy-Hot" would not have brought Smart-Relief to market and instead would have acquired rights to this product.

"Something is rotten in the state of Denmark"

All-UnAudited-Information-Credibility-Reliability-in-question
All this speculation is based on un-audited information.
This company does not provide audited financial reporting.

"All" , in particular "New" Investors would be best suited to leverage historical PPS, OS & AS also suggest inquiring regarding Family based loans when assessing potential returns from this stock.

Total-Fail-been-dreaming-for-too-long
Speculators propagating false hopes and dreams may want to wake up and smell the compost surrounding the PPS and TOXIC dilution.
PPS will continue to decline in particular will realize PPS decline near end/begin of month as company prints cash via TOXIC Dilution of shares to refill family and friends piggy banks.

Have-some-confidence-just-similar-doubts
As an investor in the company and optimistic we will have FDA clearance eventually would prefer company provide more transparency and eliminates doubts where they exist.

The doubts arise from lack of transparency and PR's that have more propensity to incite speculation than provide clear guidance on near term status of the company.

Right now opinion is 70% Share selling fiasco founded on 30% marketable product.

Significant-volume-for-trials-product-with-no-margins
What this poster fails to acknowledge in these relentless redundant repetitive messages is the fact the extrapolation is based on full priced/battery-life product.
There is lack of transparency from the company and reasonable indication that the product being shipped is "7 Day Trial" product that does not have any profit and is instead sold at a loss, likely because company has batteries nearing end of life and they need to move the product before the batteries are not reliable.

So, company seems to have derived a "7 Day Trial" campaign, very clever, to move the product by essentially giving to sales channels.

This is rational explanation for the increased sales volume yet lack of any profits in most recent "Un-Audited" financials shared from company.

Fundamentally all this hype is irrelevant if the PPS continues to decline. At this point does not matter if the company is moving product into bazillion new sales channels, if the product has negative margins then we will continue to experience TOXIC Dilution, decreased PPS, increased OS & AS and zero profits with accumulating losses and friends of the family indebtedness.

This "friends of the family indebtedness" guarantees profits for the family and all but ensures investors are taken to the cleaners.

Company-release-OS-as-part-of-financials-released
Beyond that there is no means that aware of to know the true daily/monthly... OS

In fact asking the company they will not disclose if they are or are not selling shares and increasing the OS outside of the financials being released.

Hypocrisy-if-ok-to-comment-No-Reason-not-to-have-decision-by-year-end
How can one take the position of compromising the FDA process as result of disclosing the state when the company has already stated "No Reason not to have decision by year end"

Likewise if the position of no details should be shared, then the details about even re-submitting the 510k should not have been disclosed...

This is classic irrational "Hypocrisy" common on this board.

Only interested in the information that seems to supports Speculative investment.

likewise-no-evidence-there-is-not-dilution
PPS can be +/-20% as long as new buyers are being attracted and with statements like "No reason we should not have decision by Year end" you can certainly attract new buyers.

ongoing-is-not-transparency-of-course-ongoing-otherise-we-would-have-decision
The company must have more information than "ongoing..."
Difficult to believe they are unable to share additional details, what is the harm?

Again, if the company is willing to share "There is no reason we should not have approval by year end" then the same should eb applied to disclosing what the status is after more than 5-6 months, if indeed 510K was submitted when was stipulated as having been submitted.

Company-has-same-direct-feedback-FDA-status-should-be-openly-commented-on
The future direction of the company relies on the FDA decision outcome and to not share the status in my opinion is remiss.

If company is willing to make public statements like "No reason we should not have clearance by end of year" then should be no reason why they can not share what status they have.
Even if that is as simple as we have heard ZERO from FDA.

There-is-defintaely-intelligence-behind-this-company
The problem is the unsuspecting investors getting duped by these clever individuals deriving the PR strategies that facilitate the share selling TOXIC Dilution paradigm.

If there was real potential with real viable business models and real demand for the product there would be real names like J&J buying this company.

All the hyped PR about new channels is nearly irrelevant without concrete written/reported evidence from the company the product is selling proportionally to the number of new channels being added.

Yes-we-are-closer-to-FDA-decision-also-closer-to-Hades-freezing-over
Given the transparency being provided from the company, all these speculators suggesting we are closer might as well be Pumping hades freezing over, because we are that much closer to both FDA decision and Hades freezing over.

Plenty of money to be made shorting when Hades freezes over.

PPS-stagnant-do-not-buy-above_0.0004
Ignore all the hyped speculation from incessant posters
PPS says 90% of what is needed to know for new investors
Do not buy above 5 year low of ~0.0004

No-problem-when-Shaq-begins-promoting-wearables-would-agree-there-is-a-market
Nothing like standing on the shoulders of giants both figuratively and realistically

Many companies have established market share by emulating the leaders with minor differentiation to establish a market presence

Suggest studying US market for Icy-Hot TENS and augment accordingly for Biel

PPS-will-move-relative-to-analyst-valuations-and-US-TAM-upon-FDA-clearance

Agree with comments excluding the PPS

Opinion is PPS will have 3 waves with long tail upon FDA clearance

1st wave will be FDA approval speculation, likely 10X current PPS relative to OS. Meaning if clearance is deferred for another year, which is possible, the OS will have increased and PPS decreased proportionally. This 1st wave will last 2-3 weeks after FDA announces.

2nd wave will be once frantic speculation and analysis is executed then the true valuation will be derived based on sales/profits and US TAM --> Total Addressable Market" Best comparative TAM would be Icy-Hot Smart TENS device. Does matter device uses different mechanism, the point is addressing similar market. Think all the different Viagra products, they are all after the same market. This 2nd wave will last 1-2 months after FDA announces.

So, let's say Icy-Hot has $200M US sales, then Acti-Patch would be after the same market and the Biel valuation would reflect this revenue share. Realize, Acti-Patch aint gonna get Shaq as the spokes/media person... ;) So, be realistic in expectations.

3rd wave is the long settling tail, say 6-18 months after FDA approval, this is where rubber meets the road and if Biel can execute. Opinion is product simply does not have the demand necessary to sustain PPS levels that will be reached upon FDA speculation. IE: sub-penny valuation after 3rd wave long tail regresses to mean.







3rd wave

Well-done-kudos-to-the-company

Proof-is-in-the-pudding

At this point the company has lost credibility as result of
1.) Inciting speculation about FDA Clearance by 2015 year end, which did not happen
2.) The TOXIC Dilution of the share structure.
3.) Inciting speculation based on added sales channels
While unwilling to share units sold into these same channels

Eat-Crow

Please review the definition for Exponential, any mention of exponential growth is mathematically FLAWED.

1.) The company has not released any data that would support speculating on profitability
2.) FDA Clearance is NOT inevitable and the company is also unwilling to provide any insights as to the status of the process

Bottom line the only metric we have at this time is PPS which speaks for itself.

If legitimate investors had insights that suggested profits or inevitable FDA Clearance anytime soon the PPS would be 4X what it is today.

Any opinions or assumptions that suggest having insights that would suggest profitability or FDA Clearance are not based on company released information.

At this point the company has lost credibility as result of
1.) Inciting speculation about FDA Clearance by 2015 year end, which did not happen
2.) The TOXIC Dilution of the share structure.
3.) Inciting speculation based on added sales channels
While unwilling to share units sold into these same channels

No-data-from-company-that-supports-profitability-projections

1.) The company has not released any data that would support speculating on profitability
2.) FDA Clearance is NOT inevitable and the company is also unwilling to provide any insights as to the status of the process

Bottom line the only metric we have at this time is PPS which speaks for itself.

If legitimate investors had insights that suggested profits or inevitable FDA Clearance anytime soon the PPS would be 4X what it is today.

Any opinions or assumptions that suggest having insights that would suggest profitability or FDA Clearance are not based on company released information.

At this point the company has lost credibility as result of
1.) Inciting speculation about FDA Clearance by 2015 year end, which did not happen
2.) The TOXIC Dilution of the share structure.
3.) Inciting speculation based on added sales channels
While unwilling to share units sold into these same channels

No-more-ASSumption-then-dreaming-about-FDA-Clearance-or-Profits

Deflecting-from-the-truth-PPS-is-bottom-line
If the sales were achieving levels anything close to profitability the company would be sending out PR's
The reality is the logical assumption is sales must not be anything to communicate about.

Reference-any-company-documents-that-state-channeles-not-starting-until-Jan-2016
Definitely alternate reality being referenced.